Not Yet RecruitingNot Applicable

Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass

United States100 participantsStarted 2026-05

Plain-language summary

The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age or older * Undergoing cardiac surgery with cardiopulmonary bypass at Atrium Health Wake Forest Baptist Medical Center Exclusion criteria: * Under 18 years of age * Pregnant women * Patients with a contraindication to device placement on the posterior arm, including rash, missing extremity, or existing line or device

What they're measuring

Continuous Glucose Monitoring Accuracy Compared to Point-of-Care Measurements

Timeframe: Up to Day 10

Percentage of Continuous Glucose Monitoring Accuracy with Vasopressor Use

Timeframe: Up to Day 10

Percentage of Continuous Glucose Monitoring Accuracy with Hypothermia

Timeframe: Day 1

Percentage of Continuous Glucose Monitoring Accuracy with Acidosis

Timeframe: Up to Day 10

Trial details

NCT IDNCT06861881

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10

Contact for this trial

Megan H Hicks, MD

336-716-4498 Megan.Hicks@wfusm.edu

View on ClinicalTrials.gov More Glucose Metabolism Disorders (Including Diabetes Mellitus) trials